Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

China's Largest Private Pharma Company Fosun Pharma Targets Biosimilar Market, With Sights On Becoming The Next Teva

Oct 28 2011

• By The Pink Sheet Daily

Related Content

With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?

May 10 2011

Lonza Forms JV With Shanghai Fosun To Tap Chinese Generics Market

Sep 09 2011

Shanghai Fosun Omni Pharma Execs On The Market For Inhalation Products In China: An Interview With PharmAsia News (Part 2 of 2)

Sep 08 2008

The Year Of The Tiger Looking Strong For IPOs In China Following Sinopharm Success

Dec 04 2009

China Distributor Consolidation Heats Up: Sinopharm Looks To Raise $440 Million Ahead Of Shanghai Pharma IPO

Apr 27 2011

Merck And Simcere Trial Partnership In China: Two Different Cultures But One Common Goal

Aug 22 2011

Novo Ramps Up In China, Roche Downplays Branded Generics, GSK Talks Up Japan While Hitting "The Inflection Point": Emerging Markets Round Up (Part 2)

Aug 11 2011

Additional Topics

China Asia Pacific BioPharmaceutical

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window